Canadian guidelines for intravenous thrombolytic treatment in acute stroke. A consensus statement of the Canadian Stroke Consortium.
BACKGROUND: The thromobolytic drug, tissue plasminogen activator (tPA) has been approved in the United States for the treatment of acute ischemic stroke amid controversy and concern about the balance of risk and benefit. The Canadian Stroke Consortium (CSC), a national network of neurologists who collaborate on joint projects in stroke medicine, including clinical trials and consensus statements, has developed guidelines for the use of tPA in Canada. METHODS AND RESULTS: The CSC Board of Dire...Expand abstract
- Publication status:
- Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
- Publication date:
- Source identifiers:
- Copyright date:
If you are the owner of this record, you can report an update to it here: Report update to this record